आपके बैज 52W रेंज $2–$4 15% of range विश्लेषक रेटिंग SELL 16 analysts मूल्य लक्ष्य $3 +16% upside P/E 1.5 ROE -16.7% शुद्ध लाभ मार्जिन 2.1%

CYH स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा

03
मूल्य $2.72
मार्केट कैप (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
राजस्व (TTM) $11.98B
ROE (TTM) -16.7%
D/E ऋण/इक्विटी (MRQ) -6.9
52W रेंज $2–$4

CYH स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें

04
सीमा
बार

बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।

स्टॉक विभाजन 1
एक्स-डेट स्प्लिट प्रकार
22 अप्रैल 2016 121-for-100 फॉरवर्ड

Community Health Systems, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗

Wikidata ↗

क्षेत्रHealth Care उद्योगHealth Care कर्मचारी44000 देशUS

10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान

06
राजस्व$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
फ्री कैश फ्लो$208M
2016-12-31 → 2025-12-31
शुद्ध मार्जिन2.1%
2018-12-31 → 2025-12-31
मूल्यांकन और अनुपात 07–12

मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?

मेट्रिक 5Y रुझान CYH 5Y औसत सहकर्मी माध्यिका निर्णय
P/E (TTM) 1.55Y औसत ≈3.4 ≈3.4 15.5 अल्पमूल्यित
P/S (TTM) 0.05Y औसत ≈0.1 ≈0.1 1.2 अल्पमूल्यित
P/B (MRQ) -0.35Y औसत ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.15Y औसत ≈13.1 ≈13.1 10.6 अल्पमूल्यित
मूल्य / FCF (TTM) -2.15Y औसत ≈-0.8 ≈-0.8 · ·
मूल्य / नकदी प्रवाह (TTM) 3.05Y औसत ≈-1.6 ≈-1.6 6.5 अल्पमूल्यित
EV / Revenue (EV / राजस्व) 0.85Y औसत ≈1.0 ≈1.0 · ·
EV / FCF 50.55Y औसत ≈-4.9 ≈-4.9 · ·

सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।

मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय

लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR

13
एक्स-डेटराशिमुद्रायील्ड
दिस् 13, 2012$0.21USD≈0.84%

Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि

14
औसत आश्चर्य 37.9%
अगली रिपोर्ट अक्ट 21, 2026
Periodरिपोर्टEPS ActualEPS अनुमानआश्चर्य
30 जून 2026 जुल 21, 2026 $-0.19 $-0.06 -201.1%
31 मार्च 2026 $-0.48 $-0.10 -387.3%
31 दिसमबर 2025 $-0.01 $-0.10 90.5%
30 सितमबर 2025 $1.27 $-0.25 610.5%
30 जून 2025 $-0.05 $-0.11 52.6%
31 मार्च 2025 $-0.03 $-0.08 62.6%

पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह

15
आय विवरण 13
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
बैलेंस शीट 26
मेट्रिक रुझान 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
नकदी प्रवाह 13
मेट्रिक रुझान 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
लाभप्रदता 7
मेट्रिक रुझान 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
तरलता और शोधन क्षमता 4
मेट्रिक रुझान 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
दक्षता 2
मेट्रिक रुझान 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
प्रति शेयर 5
मेट्रिक रुझान 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
विकास दरें 9
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
मूल्यांकन (TTM) 13
मेट्रिक रुझान 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·

वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष

16
मेट्रिक 2025-12-312024-12-312023-12-312022-12-312021-12-31
राजस्व $12.48B $12.63B $12.49B $12.21B $12.37B
परिचालन मार्जिन % 11.9% 4.3% 7.7% 6.7% 11.3%
शुद्ध आय $509M $-516M $-133M $46M $230M
तनुकरणित EPS $3.77 $-3.90 $-1.02 $0.35 $1.76

संस्थागत मालिक (13F) 196 फाइलर्स · $415.1M कुल · तिथि अनुसार 30 सितमबर 2026

17

संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।

धारक 196
धारित मूल्य $415.1M
नई स्थितियाँ 31
बाहर निकली पोजीशन 24
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
नई स्थितियाँ बाहर निकली पोजीशन बढ़ाया घटा हुआ शुद्ध शेयर परिवर्तन
31 (+9 पिछली तिमाही की तुलना में) 24 (+4 पिछली तिमाही की तुलना में) 69 (+6 पिछली तिमाही की तुलना में) 54 (-9 पिछली तिमाही की तुलना में) +7.0M

Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।

संस्था मूल्य शेयर % ट्रैक किए गए 13F का प्रकार
CastleKnight Management LP $44704517 13384586 10.77% शेयर
Apollo Management Holdings, L.P. $39610817 11859526 9.54% शेयर
BlackRock, Inc. $36507995 10930538 8.79% शेयर
VANGUARD GROUP INC $28605579 9168455 6.89% शेयर
Eversept Partners, LP $26267680 7864575 6.33% शेयर
NOMURA HOLDINGS INC $22388384 6703109 5.39% शेयर
VANGUARD CAPITAL MANAGEMENT LLC $17668370 5289931 4.26% शेयर
WHITEBOX ADVISORS LLC $12467362 3732743 3.00% शेयर
GEODE CAPITAL MANAGEMENT, LLC $10582352 3167702 2.55% शेयर
STATE STREET CORP $10226622 3061863 2.46% शेयर
VANGUARD PORTFOLIO MANAGEMENT LLC $10082117 3018598 2.43% शेयर
Saba Capital Management, L.P. $9626444 2882169 2.32% शेयर
Owl Creek Asset Management, L.P. $8452277 2530622 2.04% शेयर
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8176380 2448018 1.97% शेयर
DIMENSIONAL FUND ADVISORS LP $7854253 2351460 1.89% शेयर
D. E. Shaw & Co., Inc. $7829388 2344128 1.89% शेयर
AQR CAPITAL MANAGEMENT LLC $7651362 2290827 1.84% शेयर
TWO SIGMA INVESTMENTS, LP $7365822 2205336 1.77% शेयर
Diameter Capital Partners LP $6138793 1837962 1.48% शेयर
BANK OF AMERICA CORP /DE/ $5903847 1767619 1.42% शेयर
GOLDMAN SACHS GROUP INC $5868073 1756908 1.41% शेयर
TWO SIGMA ADVISERS, LP $5816476 1864255 1.40% शेयर
CARRONADE CAPITAL MANAGEMENT, LP $5230000 1565847 1.26% शेयर
Allianz Asset Management GmbH $5167919 1547281 1.24% शेयर
MORGAN STANLEY $4800489 1437272 1.16% शेयर
NORTHERN TRUST CORP $4681414 1401621 1.13% शेयर
Silver Rock Financial LP $3674000 1100000 0.89% शेयर
CITADEL ADVISORS LLC $3475360 1040527 0.84% शेयर
Assenagon Asset Management S.A. $2788275 834813 0.67% शेयर
VANGUARD FIDUCIARY TRUST CO $2642231 791087 0.64% शेयर
Jefferies Financial Group Inc. $2481286 742900 0.60% शेयर
Alta Fundamental Advisers LLC $2161411 647129 0.52% शेयर
Bank of New York Mellon Corp $2122084 635354 0.51% शेयर
MARSHALL WACE, LLP $1906575 570831 0.46% शेयर
MILLENNIUM MANAGEMENT LLC $1701580 509455 0.41% शेयर
ExodusPoint Capital Management, LP $1664603 498384 0.40% शेयर
READYSTATE ASSET MANAGEMENT LP $1657729 496326 0.40% शेयर
WOLVERINE ASSET MANAGEMENT LLC $1339674 401100 0.32% कॉल ऑप्शन
Helix Partners Management LP $1336000 400000 0.32% शेयर
Susquehanna Portfolio Strategies, LLC $1280940 383515 0.31% शेयर
Voleon Capital Management LP $1247032 373363 0.30% शेयर
Invesco Ltd. $1076599 322335 0.26% शेयर
TUDOR INVESTMENT CORP ET AL $999388 299218 0.24% शेयर
Pathstone Holdings, LLC $895621 268150 0.22% शेयर
Prescott Group Capital Management, L.L.C. $863076 258406 0.21% शेयर
UBS Group AG $851089 254817 0.21% शेयर
MILLENNIUM MANAGEMENT LLC $835000 250000 0.20% पुट ऑप्शन
FEDERATED HERMES, INC. $812599 243293 0.20% शेयर
LPL Financial LLC $737239 220730 0.18% शेयर
IEQ CAPITAL, LLC $657963 196995 0.16% शेयर

सभी 196 संस्थागत मालिक दिखाएँ →

कार्यकर्ता और 5%+ मालिक 1 होल्डिंग

18

जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।

फाइलर दाखिल किया दांव स्थिति उद्देश्य फाइलिंग
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 फाइलिंग 11 मार्च 2021 · प्रारंभिक फाइलिंग · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

कंपनी के अंदरूनी सूत्र 56 इनसाइडर्स · 29 अधिकारी · 23 निदेशक

19
अंदरूनी भूमिका अंतिम गतिविधि शेयरों का स्वामित्व खरीद 12m बिक्री 12m नेट 12m
Kevin J Hammons CEO 1 मार्च 2026 A 895545 0 0 $0
Tim Hingtgen CEO 1 मार्च 2025 A 1388781 0 0 $0
Jason K Johnson EVP & CFO 1 मार्च 2026 A 268439 0 0 $0
Thomas J Aaron EVP and CFO 7 दिसमबर 2019 F 241515 0 0 $0
Larry W Cash President and CFO 1 मार्च 2017 A 568152 0 0 $0
Miguel S Benet President and CMO 1 मार्च 2025 D 47635 0 0 $0
Austen D Mason Regional President 1 मार्च 2025 A 142500 0 0 $0
Mark B Medley Regional President 1 मार्च 2025 A 128637 0 0 $0
Chad A Campbell Regional President 1 मार्च 2025 A 136815 0 0 $0
Charles J Cova Regional President 1 मार्च 2024 A 58701 0 0 $0
Lynn T Simon President and CMO 1 मार्च 2024 A 482657 0 0 $0
Beryl Ramsey Division President 1 मार्च 2019 A 62969 0 0 $0
Patton Paul Smith Division President 1 मार्च 2019 F 119017 0 0 $0
Iii John W Mcclellan Division President 1 मार्च 2017 A 41242 0 0 $0
Robert O Horrar Division President 1 मार्च 2017 A 68649 0 0 $0
Martin Bonick Division President 1 मार्च 2017 A 100458 0 0 $0
Michael T Portacci Division President 1 मार्च 2017 A 110156 0 0 $0
Thomas Daniel Miller Division President 1 मार्च 2016 A 112107 0 0 $0
David Lewis Miller President and COO 1 मार्च 2016 A 440840 0 0 $0
William S Hussey Division President 28 अक्टूबर 2015 M 121568 0 0 $0
Martin Dewayne Smith Division President 3 जून 2015 M 94111 0 0 $0
Gary D Newsome Division President - Group Ops 25 अगस्त 2008 M 118286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1 जून 2026 A 30000 0 0 $0
Phillip A. Posey SVP & CAO 1 मार्च 2026 A 51736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1 मार्च 2026 A 287750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1 मार्च 2026 A 208290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1 मार्च 2017 F 243065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25 फ़रवरी 2012 F 78379 0 0 $0
Martin G Schweinhart Senior Vice President 1 मार्च 2006 A 40354 0 0 $0
William Norris Jennings निदेशक 25 अगस्त 2026 S 38468 0 1 $-118400
Ranga K Krishnan निदेशक 30 जून 2026 M 170023 0 0 $0
Fawn D Lopez निदेशक 1 मार्च 2026 A · 0 0 $0
Ronald L Burgess JR निदेशक 1 मार्च 2026 A · 0 0 $0
Susan W Brooks निदेशक 1 मार्च 2026 A 108695 0 0 $0
Hubert James Williams निदेशक 1 मार्च 2026 A 211863 0 0 $0
Joseph Arthur Hastings निदेशक 1 मार्च 2026 A 0 0 0 $0
Elizabeth T Hirsch निदेशक 1 मार्च 2026 A 162059 0 0 $0
James S. Ely III निदेशक 1 मार्च 2026 A 412876 0 0 $0
John A Fry निदेशक 1 मार्च 2026 A 268966 0 0 $0
John A Clerico निदेशक 1 मार्च 2026 A 368763 0 0 $0
Michael Dinkins निदेशक 1 मार्च 2026 A 225882 0 0 $0
Wayne T Smith निदेशक 1 मार्च 2026 A 5217579 0 0 $0
Julia B North निदेशक 1 मार्च 2021 A 162056 0 0 $0
Mitchell H Watson JR निदेशक 16 मई 2017 M 22594 0 0 $0
Harvey Klein MD निदेशक 15 मार्च 2010 M 10383 0 0 $0
Dale F Frey निदेशक 31 मार्च 2008 A 20000 0 0 $0
Thomas H Lister निदेशक 21 सितमबर 2004 S 0 0 0 $0
Thodore Forstmann निदेशक 21 सितमबर 2004 S 0 0 0 $0
Sandra Horbach निदेशक 21 सितमबर 2004 S 0 0 0 $0
Robert J Dole निदेशक 6 मई 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10% मालिक 21 सितमबर 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10% मालिक 21 सितमबर 2004 S 0 0 0 $0
Winston Hutchins 10% मालिक 21 सितमबर 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10% मालिक 21 सितमबर 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10% मालिक 21 सितमबर 2004 S 0 0 0 $0
Benjamin C Fordham · 1 मार्च 2021 A 254608 0 0 $0

SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S

ईटीएफ स्वामित्व 25 ETFs द्वारा धारित

20

वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।

फंड भार इकाइयाँ तिथि अनुसार स्रोत
BSJR · Invesco Exchange-Traded Self-Indexe… 2.68% 23297000 1 अक्टूबर 2026 दैनिक
EBIT · Harbor ETF Trust 0.45% 19210 NS 31 जुलाई 2026 N-PORT
IWC · iShares Trust 0.09% 443690 SH 11 सितमबर 2026 दैनिक
IHF · iShares Trust 0.05% 223947 SH 11 सितमबर 2026 दैनिक
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 113109 SH 19 अगस्त 2026 दैनिक
NEAR · iShares U.S. ETF Trust 0.03% 1340000 SH 11 सितमबर 2026 दैनिक
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 226491 SH 1 अक्टूबर 2026 दैनिक
IWM · iShares Trust 0.01% 3425206 SH 11 सितमबर 2026 दैनिक
RSSL · Global X Funds 0.01% 62038 NS 31 जुलाई 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 746733 SH 19 अगस्त 2026 दैनिक
VHT · VANGUARD WORLD FUND 0.01% 349881 SH 19 अगस्त 2026 दैनिक
DFAS · Dimensional ETF Trust 0.01% 289348 NS 31 जुलाई 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 202789 NS 31 जुलाई 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 33838 NS 31 जुलाई 2026 N-PORT
ITOT · iShares Trust 0.00% 203848 SH 11 सितमबर 2026 दैनिक
IWV · iShares Trust 0.00% 42177 SH 3 सितमबर 2026 दैनिक
DCOR · Dimensional ETF Trust 0.00% 6184 NS 31 जुलाई 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 31135 NS 31 जुलाई 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 1347195 SH 19 अगस्त 2026 दैनिक
VTI · VANGUARD INDEX FUNDS 0.00% 3813888 SH 19 अगस्त 2026 दैनिक
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 9817 SH 19 अगस्त 2026 दैनिक
DFSU · Dimensional ETF Trust 0.00% 24 NS 31 जुलाई 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15 जुलाई 2026 दैनिक
VPLS · VANGUARD MALVERN FUNDS · · 15 जुलाई 2026 दैनिक
IWN · iShares Trust · 1223127 SH 11 सितमबर 2026 दैनिक

CYH विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड

21
रेटिंग · 16 विश्लेषक होल्ड
मध्यिका लक्ष्य $3.12 +14.9%
1 6.2% मजबूत खरीद
1 6.2% खरीदें
6 37.5% होल्ड
7 43.8% बेचें
1 6.2% मजबूत बिक्री

12-महीने का मूल्य लक्ष्य

8 विश्लेषक · 2026-10-01

माध्य लक्ष्य $3.16 +16.0%

अभी वर्तमान मूल्य $2.72
निम्न$2.00 माध्य$3.16 उच्च$4.00

सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी

22

वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।

टिकर मार्केट कैप P/E राजस्व YoY शुद्ध मार्जिन ROE सकल मार्जिन
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां

23

मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ

26

उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।

आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।

स्रोत: SEC 10-Q जुल 23, 2026 को फाइल किया गया